According to the report released by the Pharmaceutical Research and Producers of America (PhRMA), more than 900 new medicines are actually within the analysis and growth pipeline to deal with the ailments of aging. The new medicines embrace 146 medicines for coronary heart illness and stroke and 399 for cancer. All of these medicines are both now in human clinical trials or are awaiting the approval of the Meals and Drug Administration.